Beacon Investment Advisory Services’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Hold |
14,000
| – | – | 0.01% | 247 |
|
|
2025
Q1 | $103K | Hold |
14,000
| – | – | ﹤0.01% | 236 |
|
|
2024
Q4 | $120K | Hold |
14,000
| – | – | 0.01% | 246 |
|
|
2024
Q3 | $122K | Hold |
14,000
| – | – | 0.01% | 252 |
|
|
2024
Q2 | $95.8K | Hold |
14,000
| – | – | ﹤0.01% | 261 |
|
|
2024
Q1 | $127K | Hold |
14,000
| – | – | 0.01% | 262 |
|
|
2023
Q4 | $62.4K | Buy |
14,000
+2,000
| +17% | +$8.92K | ﹤0.01% | 263 |
|
|
2023
Q3 | $37.7K | Hold |
12,000
| – | – | ﹤0.01% | 271 |
|
|
2023
Q2 | $61.9K | Hold |
12,000
| – | – | ﹤0.01% | 277 |
|
|
2023
Q1 | $63.2K | Hold |
12,000
| – | – | ﹤0.01% | 276 |
|
|
2022
Q4 | $33.7K | Hold |
12,000
| – | – | ﹤0.01% | 277 |
|
|
2022
Q3 | $50K | Hold |
12,000
| – | – | ﹤0.01% | 272 |
|
|
2022
Q2 | $48K | Hold |
12,000
| – | – | ﹤0.01% | 281 |
|
|
2022
Q1 | $59K | Hold |
12,000
| – | – | ﹤0.01% | 297 |
|
|
2021
Q4 | $84K | Hold |
12,000
| – | – | ﹤0.01% | 305 |
|
|
2021
Q3 | $120K | Hold |
12,000
| – | – | 0.01% | 295 |
|
|
2021
Q2 | $170K | Hold |
12,000
| – | – | 0.01% | 296 |
|
|
2021
Q1 | $197K | Buy |
12,000
+2,000
| +20% | +$32.8K | 0.01% | 290 |
|
|
2020
Q4 | $207K | Hold |
10,000
| – | – | 0.01% | 270 |
|
|
2020
Q3 | $76K | Hold |
10,000
| – | – | ﹤0.01% | 251 |
|
|
2020
Q2 | $83K | Hold |
10,000
| – | – | ﹤0.01% | 242 |
|
|
2020
Q1 | $50K | Hold |
10,000
| – | – | ﹤0.01% | 231 |
|
|
2019
Q4 | $40K | Buy |
+10,000
| New | +$40K | ﹤0.01% | 243 |
|